Your browser doesn't support javascript.
loading
A phenotypic expansion of TRNT1 associated sideroblastic anemia with immunodeficiency, fevers, and developmental delay.
Odom, John; Amin, Hitha; Gijavanekar, Charul; Elsea, Sarah H; Kralik, Stephen; Chinen, Javier; Lin, Yuezhen; Yates, Amber Meshell Mayfield; Mizerik, Elizabeth; Potocki, Lorraine; Scaglia, Fernando.
Afiliação
  • Odom J; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Amin H; Texas Children's Hospital, Houston, Texas, USA.
  • Gijavanekar C; Texas Children's Hospital, Houston, Texas, USA.
  • Elsea SH; Cortica Care, Irvine, California, USA.
  • Kralik S; Section of Child Neurology and Neurodevelopmental Disabilities, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Chinen J; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Lin Y; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Yates AMM; Texas Children's Hospital, Houston, Texas, USA.
  • Mizerik E; Department of Radiology, Baylor College of Medicine, Houston, Texas, USA.
  • Potocki L; Division of Allergy and Immunology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Scaglia F; Division of Endocrinology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Am J Med Genet A ; 188(1): 259-268, 2022 01.
Article em En | MEDLINE | ID: mdl-34510712
ABSTRACT
Sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD; MIM #616084) is an autosomal recessive disorder of mitochondrial and cytosolic tRNA processing caused by pathogenic, biallelic variants in TRNT1. Other features of this disorder include central nervous system, renal, cardiac, ophthalmological features, and sensorineural hearing impairment. SIFD was first described in 2013 and to date, it has been reported in 46 patients. Herein, we review the literature and describe two siblings with SIFD and note the novel phenotype of hypoglycemia in the context of growth hormone (GH) deficiency. GH deficiency without hypoglycemia has previously been reported in three patients with SIFD, but GH deficiency had not been firmly ascribed to SIFD. We propose to expand the phenotype to include GH deficiency, hypoglycemia, and previously unreported dysmorphic features. Furthermore, we highlight the intrafamilial variability of the disease by the discordance of our patients' clinical phenotypes and biochemical profiles measured by untargeted metabolomics analysis. Several metabolomic abnormalities were observed in both patients, and these may represent a potential biochemical signature for SIFD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anemia Sideroblástica Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anemia Sideroblástica Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article